Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Published:2012-05-10 Issue:13 Volume:18 Page:3686-3696
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Sawada Yu,Yoshikawa Toshiaki,Nobuoka Daisuke,Shirakawa Hirofumi,Kuronuma Toshimitsu,Motomura Yutaka,Mizuno Shoichi,Ishii Hiroshi,Nakachi Kohei,Konishi Masaru,Nakagohri Toshio,Takahashi Shinichiro,Gotohda Naoto,Takayama Tadatoshi,Yamao Kenji,Uesaka Katsuhiko,Furuse Junji,Kinoshita Taira,Nakatsura Tetsuya

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma;Cancers;2024-07-22

2. Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma;Cancers;2024-07-03

3. Immunotherapy for hepatocellular carcinoma;Chinese Medical Journal;2024-06-07

4. Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma;Frontiers of Medicine;2024-06-04

5. Treatment options for advanced hepatocellular carcinoma: the potential of biologics;Expert Opinion on Biological Therapy;2024-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP